This includes recruitment of Tregs to the TME and a “M2-like polarization” of TAMs (54), as well as an increased tumor PD-L1 expression and a heightened fraction of exhausted PD-1+/TIM-3+ CD8+ T cells (80, 113). The gene discussed is CD8A; the disease is neoplasm.